Org chart
Christopher Anzalone
President & CEO
Christopher Anzalone
Collapse
Patrick C. O’Brien
COO & General Counsel
Tracie Oliver
Chief Commercial Officer
James Hamilton
Chief Discovery & Translational Medicine
Randy Steiner
VP, Regulatory Affairs
Thomas Schluep
VP, Program Management
Dave Bormett
VP, Quality Assurance
Jack Shi
VP, Clinical Pharmacology
Fred Fleitz
GVP, Chemistry, Manufacturing & Controls
Zhi-Ming Ding
VP, Biology
Tao Pei
GVP, Chemistry
Erik Bush
GVP, Biology
Christine Esau
VP, Biology
Peter Carignan
VP, Clinical Operations
Leslie Lemke-Boutcher
VP, Nonclinical Toxicology
